Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies. [PDF]
Abstract The rapid expansion of psychedelic research has opened significant pathways of opportunity in treating mental health disorders. Participants in recent clinical trials consistently report mystical-type experiences during dosing sessions, and some scholars posit that such experiences themselves help mediate clinical ...
Lewis SP +11 more
europepmc +4 more sources
Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective. [PDF]
Psychedelic-assisted therapy (PAT) is an emerging intervention in psychiatry, for which there is preliminary evidence for effectiveness in eating disorders (EDs).
Koning E +6 more
europepmc +3 more sources
The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
Introduction: Psychedelic-assisted psychotherapy is a promising approach in psychiatry; evidence is growing and it may not be long before mainstream services are expected to offer it to selected patients.
Lisa A. Page +5 more
doaj +2 more sources
Perceptions of Psychedelic-Assisted Therapy Among Black Americans
The present study investigated differences in perceptions of psychedelic-assisted therapy between Black and White Americans, as well as factors that may influence these perceptions. A final sample of 294 adults (42% female, 44% Black/African American or Mixed Race (of Black/African ancestry), 56% White American; Mage = 36.3 years) completed an online ...
Callan Coghlan +2 more
exaly +3 more sources
Ensuring Access to Psychedelic-Assisted Therapy in Rural Communities. [PDF]
With several classical psychedelics being designated as breakthrough therapies and the recent review of a New Drug Application for 3,4-Methylenedioxymethamphetamine in the treatment of posttraumatic stress disorder, the likelihood of psychedelic medication becoming approved for clinical use in the United States is high.
Dhaliwal OM, Bobak L, Barnett BS.
europepmc +4 more sources
Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy. [PDF]
Psychedelics have recently re‐emerged as potential treatments for various psychiatric conditions that impose major public health costs and for which current treatment options have limited efficacy. At the same time, personalized medicine is increasingly being implemented in psychiatry to provide individualized drug dosing recommendations based on ...
Halman A +5 more
europepmc +3 more sources
Expert recommendations for Germany's integration of psychedelic-assisted therapy. [PDF]
As clinical trials for psychedelics move into phase III in the USA, Europe must address its lag in integrating professional education around psychedelic-assisted therapy (PAT) and supporting psychedelic drug research. This paper evaluates the necessary frameworks for implementing PAT in Germany, emphasizing the nation’s potential leadership role within
Perez Rosal SR +5 more
europepmc +4 more sources
'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy. [PDF]
Abstract Objectives Psychedelic‐assisted therapy (PAT) frequently utilises a “cotherapy” model, in which two therapists jointly support participants throughout dosing and psychotherapy sessions. While common in clinical trials, participant experiences of cotherapy remain underexplored.
Ham R +3 more
europepmc +2 more sources
On the need for metaphysics in psychedelic therapy and research
The essential proposal of this text is that psychedelic-induced metaphysical experiences should be integrated and evaluated with recourse to metaphysics.
Peter Sjöstedt-Hughes +1 more
doaj +1 more source
The “Third” Eye: Ethics of Video Recording in the Context of Psychedelic-Assisted Therapy
In light of high-profile cases of sexual assault and other unethical conduct by therapists, recent clinical research involving psychedelic drugs has generally mandated the video recording of therapy sessions.
Khaleel Rajwani
doaj +1 more source

